X-100594282-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The ENST00000373031.5(TNMD):c.343G>A(p.Val115Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000117 in 1,195,426 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. V115V) has been classified as Likely benign.
Frequency
Genomes: 𝑓 0.0000091 ( 0 hom., 0 hem., cov: 21)
Exomes 𝑓: 0.000012 ( 0 hom. 3 hem. )
Consequence
TNMD
ENST00000373031.5 missense
ENST00000373031.5 missense
Scores
2
8
7
Clinical Significance
Conservation
PhyloP100: 4.69
Genes affected
TNMD (HGNC:17757): (tenomodulin) This gene encodes a protein that is related to chondromodulin-I, which is a cartilage-specific glycoprotein that functions to stimulate chondrocyte growth and to inhibit tube formation of endothelial cells. This protein is also an angiogenesis inhibitor. Genetic variation in this gene is associated with a risk for type 2 diabetes, central obesity and serum levels of systemic immune mediators in a body size-dependent manner. This gene is also a candidate gene for age-related macular degeneration, though a direct link has yet to be demonstrated. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Hemizygotes in GnomAdExome4 at 3 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNMD | NM_022144.3 | c.343G>A | p.Val115Met | missense_variant | 4/7 | ENST00000373031.5 | NP_071427.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNMD | ENST00000373031.5 | c.343G>A | p.Val115Met | missense_variant | 4/7 | 1 | NM_022144.3 | ENSP00000362122 | P1 | |
TNMD | ENST00000485971.1 | n.434G>A | non_coding_transcript_exon_variant | 2/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000910 AC: 1AN: 109851Hom.: 0 Cov.: 21 AF XY: 0.00 AC XY: 0AN XY: 32095
GnomAD3 genomes
AF:
AC:
1
AN:
109851
Hom.:
Cov.:
21
AF XY:
AC XY:
0
AN XY:
32095
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000170 AC: 3AN: 176321Hom.: 0 AF XY: 0.0000163 AC XY: 1AN XY: 61231
GnomAD3 exomes
AF:
AC:
3
AN:
176321
Hom.:
AF XY:
AC XY:
1
AN XY:
61231
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000120 AC: 13AN: 1085575Hom.: 0 Cov.: 27 AF XY: 0.00000852 AC XY: 3AN XY: 352171
GnomAD4 exome
AF:
AC:
13
AN:
1085575
Hom.:
Cov.:
27
AF XY:
AC XY:
3
AN XY:
352171
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000910 AC: 1AN: 109851Hom.: 0 Cov.: 21 AF XY: 0.00 AC XY: 0AN XY: 32095
GnomAD4 genome
AF:
AC:
1
AN:
109851
Hom.:
Cov.:
21
AF XY:
AC XY:
0
AN XY:
32095
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 13, 2023 | The c.343G>A (p.V115M) alteration is located in exon 4 (coding exon 4) of the TNMD gene. This alteration results from a G to A substitution at nucleotide position 343, causing the valine (V) at amino acid position 115 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D
MetaSVM
Uncertain
D
MutationAssessor
Benign
L
MutationTaster
Benign
D
PrimateAI
Pathogenic
T
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Loss of catalytic residue at V115 (P = 0.022);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at